Table 2.
Main clinical characteristics and results of the tests performed for detection of coronary abnormalities
| Total, n = 37 | |
|---|---|
| Male sex, n (%) | 22 (59 %) |
| Age at exam (year) | 13.6 ± 3 |
| BSA | 1.4 ± 0.5 |
| Indications | |
| Transition to adult clinic | 7 (19 %) |
| Chest pain/clinical deterioration | 7 (19 %) |
| Follow-up | 13 (35 %) |
| Coronary disease previously found at cath/MRI | 10 (27 %) |
| Diagnosis | |
| TGS S/P ASO | 9 (24 %) |
| Kawasaki disease | 7 (19 %) |
| Heart transplant | 11 (30 %) |
| Congenital coronary abnormality | 9 (24 %) |
| Other | 1 (3 %) |
| Patient on medication, n (%) | 2 (6 %) |
| Beta blockers | 0 (0 %) |
| Calcium channel blockers | 0 (0 %) |
| Ace inhibitor | 2 (6 %) |
| Termination due to muscular exhaustion, n (%) | 37 (100 %) |
| ECG abnormalities during stress, n (%) | 3 (8 %) |
| Arrhythmia, n (%) | 0 (0 %) |
| Symptoms | 1 (3 %) |
| Rest HR (bpm) | 87 ± 12.2 |
| Peak HR (bpm) | 155.7 ± 17.9 |
| Coronary angiograms available, n (%) | 20 (54 %) |
| Cardiac MRI available, n (%) | 21 (57 %) |
| Coronary angio or MRI available | 26 (70 %) |